---
title: "Yale Catriona — Ownership Dossier"
canonical: https://whiteintel.dev/entity/086dd371-e33d-5e4b-816a-e0724004a774
json: https://whiteintel.dev/api/public/dossier/086dd371-e33d-5e4b-816a-e0724004a774
identifier: sec:0001779308
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Yale Catriona

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001779308`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/086dd371-e33d-5e4b-816a-e0724004a774  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/086dd371-e33d-5e4b-816a-e0724004a774  

## Ownership & control

### Holdings / subsidiaries

- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **Akero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Yale Catriona**. Human view: https://whiteintel.dev/entity/086dd371-e33d-5e4b-816a-e0724004a774 · Structured JSON: https://whiteintel.dev/api/public/dossier/086dd371-e33d-5e4b-816a-e0724004a774._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._